Trust Investment Advisors Bristol Myers Squibb CO Transaction History

Trust Investment Advisors

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $613,812 - $690,358	-10,344 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $34,874 - $39,519	604 Added 6.2%	10,344 $642,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $25,269 - $28,001	440 Added 4.73%	9,740 $587,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $8,223 - $9,613	-150 Reduced 1.59%	9,300 $547,000
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $6,960 - $10,114	-150 Reduced 1.56%	9,450 $527,000
Q4 2019 Feb 03, 2020	SELL	$49.21 - $64.19 $105,801 - $138,008	-2,150 Reduced 18.3%	9,600 $616,000
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $4,277 - $5,071	-100 Reduced 0.84%	11,750 $596,000
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $63,583 - $70,309	-1,425 Reduced 10.73%	11,850 $537,000
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $78,960 - $94,150	1,750 Added 15.18%	13,275 $633,000
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $186,507 - $241,854	-3,825 Reduced 24.92%	11,525 $599,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $6,898 - $7,781	125 Added 0.82%	15,350 $953,000
Q1 2018 May 29, 2018	SELL	$59.92 - $68.98 $77,896 - $89,674	-1,300 Reduced 7.87%	15,225 $963,000
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $29,970 - $32,674	-500 Reduced 2.94%	16,525 $1.01 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $940,290 - $1.09 Million	17,025	17,025 $1.09 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Trust Investment Advisors with notifications on news.